Viva Biotech Holdings (VB0) — Cash Flow Quality Index
Viva Biotech Holdings (VB0) has a Cash Flow Quality Index of 313.38x as of June 2023. Operating cash flow of €158.72 Million exceeds net income of €506.50K, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Viva Biotech Holdings for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Viva Biotech Holdings Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Viva Biotech Holdings across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Viva Biotech Holdings tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Viva Biotech Holdings (2016–2024)
Year-by-year earnings quality comparison for Viva Biotech Holdings. For live market cap and the full company financial profile, see VB0 market cap.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | €373.99 Million | €167.29 Million | ▲ +725.9% |
| 2021 | 0.27x | €77.83 Million | €287.55 Million | ▲ +56.4% |
| 2019 | 0.17x | €46.01 Million | €265.90 Million | ▲ +29.4% |
| 2018 | 0.13x | €12.11 Million | €90.55 Million | ▼ -63.4% |
| 2017 | 0.37x | €27.89 Million | €76.26 Million | ▼ -57.6% |
| 2016 | 0.86x | €21.12 Million | €24.47 Million | — |